Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anna Colomba
Institutions:
Candiolo Cancer Institute,
University of Turin
Observed institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Candiolo Cancer Institute,
University of Turin
ORCID:
0009-0002-2675-8015
Observed ORCID:
0009-0002-2675-8015
OpenAlex ID:
A5041146836
Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study
2023
·
Anna Astarita
, Giulia Mingrone
, et al.
·
Cancers
·
10
PDF
Validation of the HFA-ICOS Score for Carfilzomib-Induced Cardiotoxicity in Multiple Myeloma: A Real-Life Perspective Study
2025
·
Anna Astarita
, Giulia Mingrone
, et al.
·
Cancers
·
6
PDF
Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience
2023
·
Giulia Mingrone
, Anna Astarita
, et al.
·
Cancers
·
6
PDF
Blood pressure variability as predictor of cancer therapy-related cardiovascular toxicity in patients with Multiple Myeloma
2025
·
Elvira Fanelli
, Giulia Picca
, et al.
·
Hypertension Research
·
5
PDF
Heart failure with preserved ejection fraction: from echocardiographic characteristics to a cardiovascular damage score in a high-risk hypertensive population
2024
·
Dario Leone
, Fabrizio Vallelonga
, et al.
·
Journal of Hypertension
·
4
Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment
2024
·
Anna Colomba
, Anna Astarita
, et al.
·
Cancers
·
3
PDF
The Emerging Role of Left Atrial Strain in Cardiovascular Risk Stratification for Multiple Myeloma Patients Undergoing Carfilzomib Therapy
2025
·
Anna Colomba
, Lorenzo Airale
, et al.
·
Cancers
·
2
PDF
“Short-term prognosis of hypertensive emergencies and urgencies: second preliminary report of the ongoing Italian multicenter ERIDANO study”
2026
·
Fabrizio Vallelonga
, Marco Cesareo
, et al.
·
Hypertension Research
·
1
Correction: Colomba et al. Haemodynamic Forces: Emerging Markers of Ventricular Remodelling in Multiple Myeloma Cardiovascular Baseline Risk Assessment. Cancers 2024, 16, 3081
2024
·
Anna Colomba
, Anna Astarita
, et al.
·
Cancers
·
1
Patients With Very High Risk of Cardiovascular Adverse Events During Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience
2023
·
Giulia Mingrone
, Anna Astarita
, et al.
·
Journal of Hypertension
·
1
Sex-specific differences in clinical characteristics and organ damage in Hypertensive Urgencies
2026
·
Elvira Fanelli
, Fabrizio Vallelonga
, et al.
·
Internal and Emergency Medicine
The Emerging Role of Left Atrial Strain in Cardiovascular Risk Stratification for Multiple Myeloma Patients Undergoing Carfilzomib Therapy
2025
·
Anna Colomba
, Lorenzo Airale
, et al.
·
Journal of Hypertension
Blood Pressure Variability as Predictor of Cancer Therapy-related Cardiovascular Toxicity in Patients With Multiple Myeloma
2024
·
Elvira Fanelli
, Giulia Picca
, et al.
·
Journal of Hypertension
Carfilzomib-based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascu-lar Events and Organ Damage in Carfilzomib-dexamethasone Versus Carfil-zomib-lenalidomide
2023
·
Anna Astarita
, Giulia Mingrone
, et al.
·
Journal of Hypertension
How age and gender affect hemodynamic forces in healthy subjects: Selected Abstract – Spring Meeting 2023
2023
·
Lorenzo Airale
, Simona Votta
, et al.
·
European Atherosclerosis Journal
PDF
Show more works
View as search
Works count:
15
Citation count:
39
H-index:
4
I10-index:
1
Year
Topic
Type